Jubilant Pharmova Q1 PAT Jumps 49% to ₹103 Crore

Jubilant Pharmova on Tuesday reported a 49% increase in profit after tax to Rs 103 crore for the first quarter ended June 30, 2025.

The company reported a normalised profit after tax PAT of ₹69 crore in the June quarter of the last fiscal.

The company said the reported PAT in Q1 of FY25 stood at ₹482 crore due to one-time net exceptional income of ₹396 crore.

Revenue from operations rose to ₹1,901 crore in the April-June quarter as compared with ₹1,732 crore in the year-ago period, Jubilant Pharmova said in a regulatory filing.

"It is heartening to note that we delivered solid revenue growth across all of our business units, and we expect this growth momentum to grow stronger as we move forward," Jubilant Pharmova Chairman Shyam S Bhartia said.

Jubilant Pharmova shares were trading 1.88% down at ₹1,151.70 apiece on BSE.